Clinical trials in Santa Monica, CA

44 recruiting studies have a site in or near Santa Monica, CA, California.

Top conditions here

All conditions

Showing 40 of 44 studies

RecruitingPhase not listedNCT06297291

Global Paradise System US Post Approval Study

Sponsor: ReCor Medical, Inc.

Long Beach, CA · Los Angeles, CA · Sacramento, CA · +43 more sites

RecruitingPhase 3NCT07028853

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Sponsor: Pfizer

Alhambra, CA · Atascadero, CA · Beverly Hills, CA · +124 more sites

RecruitingPhase 1NCT07094204

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Sponsor: Astellas Pharma Inc

Santa Monica, CA · +10 more sites

RecruitingPhase 3NCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Sponsor: Bristol-Myers Squibb

Encinitas, CA · Encino, CA · Fountain Valley, CA · +119 more sites

RecruitingPhase 3NCT07174336

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Sponsor: Eli Lilly and Company

Clovis, CA · Duarte, CA · Emeryville, CA · +126 more sites

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Los Angeles, CA · Palo Alto, CA · San Francisco, CA · +28 more sites

RecruitingPhase 3NCT06997497

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Sponsor: Merck Sharp & Dohme LLC

Fountain Valley, CA · Los Angeles, CA · Sacramento, CA · +45 more sites

RecruitingPhase 1NCT07114601

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Sponsor: Eli Lilly and Company

Duarte, CA · Santa Monica, CA · Stanford, CA · +13 more sites

RecruitingPhase 2 / Phase 3NCT07005102

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Sponsor: AbbVie

Duarte, CA · Irvine, CA · Los Angeles, CA · +15 more sites

RecruitingNot applicableNCT07069738

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

Sponsor: Boston Scientific Corporation

La Jolla, CA · Los Angeles, CA · Oakland, CA · +39 more sites

RecruitingPhase 1NCT07164313

A Study of ZW251 in Participants With Advanced Solid Tumors

Sponsor: Zymeworks BC Inc.

San Francisco, CA · Santa Monica, CA · +6 more sites

RecruitingPhase 1NCT07085091

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Sponsor: ALX Oncology Inc.

La Jolla, CA · Santa Monica, CA · +10 more sites

RecruitingPhase 1NCT05877599

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Sponsor: AstraZeneca

Duarte, CA · Los Angeles, CA · Newport Beach, CA · +17 more sites

RecruitingNot applicableNCT06453928

Starting Technology in At Risk Type 1 Diabetes Study

Sponsor: University of California, Los Angeles

Santa Monica, CA · Sylmar, CA · Torrance, CA

RecruitingPhase 3NCT07225946

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Janssen Research & Development, LLC

Fountain Valley, CA · La Jolla, CA · Los Alamitos, CA · +56 more sites

RecruitingPhase 1NCT07229313

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Sponsor: Kivu Bioscience Inc.

Santa Monica, CA · +1 more sites

RecruitingPhase 3NCT06561386

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Sponsor: Bristol-Myers Squibb

Los Angeles, CA · Sacramento, CA · San Francisco, CA · +53 more sites

RecruitingNot applicableNCT07214532

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Sponsor: Natera, Inc.

Greenbrae, CA · Loma Linda, CA · Los Alamitos, CA · +46 more sites

RecruitingPhase 2NCT07449702

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Sponsor: Oruka Therapeutics, Inc.

Fountain Valley, CA · Los Angeles, CA · San Diego, CA · +19 more sites

RecruitingPhase 2 / Phase 3NCT06780670

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Sponsor: Novartis Pharmaceuticals

Los Angeles, CA · Palo Alto, CA · +32 more sites

RecruitingPhase 1NCT06858813

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

Sponsor: AbbVie

Duarte, CA · Irvine, CA · Los Angeles, CA · +7 more sites

RecruitingPhase 3NCT07213674

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Sponsor: Amgen

Duarte, CA · Fullerton, CA · +42 more sites

RecruitingPhase 1NCT05983432

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sponsor: SystImmune Inc.

Beverly Hills, CA · Duarte, CA · Orange, CA · +19 more sites

RecruitingPhase 1NCT06888193

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Sponsor: UCB Biopharma SRL

Santa Monica, CA · +5 more sites

RecruitingPhase 2NCT06797635

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Sponsor: Merck Sharp & Dohme LLC

Santa Monica, CA · +7 more sites

RecruitingPhase 3NCT06072612

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Sponsor: BriaCell Therapeutics Corporation

Anaheim, CA · Bakersfield, CA · Beverly Hills, CA · +76 more sites

RecruitingPhase 1 / Phase 2NCT06892548

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Sponsor: BioNTech SE

Beverly Hills, CA · Los Angeles, CA · Santa Monica, CA · +14 more sites

RecruitingPhase 1NCT06586515

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Sponsor: Eli Lilly and Company

Duarte, CA · Santa Monica, CA · +23 more sites

RecruitingPhase 3NCT05232916

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Sponsor: Greenwich LifeSciences, Inc.

Duarte, CA · Fullerton, CA · Irvine, CA · +48 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Arroyo Grande, CA · Berkeley, CA · +825 more sites

RecruitingNot applicableNCT07207122

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

Sponsor: Sanmai Technologies PBC dba Sanmai

Santa Monica, CA · +3 more sites

RecruitingPhase 1NCT06179160

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Sponsor: Incyte Corporation

Palo Alto, CA · Santa Monica, CA · +11 more sites

RecruitingPhase 1 / Phase 2NCT05098132

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Sponsor: Synthekine

Beverly Hills, CA · Fullerton, CA · La Jolla, CA · +30 more sites

RecruitingPhase 2NCT06937177

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Sponsor: Endevica Bio

Los Angeles, CA · Santa Monica, CA · +23 more sites

RecruitingPhase 1 / Phase 2NCT03972657

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Sponsor: Regeneron Pharmaceuticals

Santa Monica, CA · +23 more sites

RecruitingPhase 1NCT04389632

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Anaheim, CA · Fullerton, CA · +103 more sites

RecruitingPhase 1 / Phase 2NCT04421820

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Sponsor: Bold Therapeutics, Inc.

Santa Monica, CA · +1 more sites

RecruitingPhase 1 / Phase 2NCT05379985

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Sponsor: Revolution Medicines, Inc.

Orange, CA · Santa Monica, CA · +19 more sites

RecruitingPhase 2NCT06524830

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Sponsor: atai Therapeutics, Inc.

Garden Grove, CA · Glendale, CA · La Jolla, CA · +31 more sites

RecruitingPhase 1 / Phase 2NCT05785741

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Sponsor: DualityBio Inc.

Sacramento, CA · Santa Monica, CA · +13 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.